AmerisourceBergen (NYSE:ABC) Getting Somewhat Positive News Coverage, Accern Reports

Headlines about AmerisourceBergen (NYSE:ABC) have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. AmerisourceBergen earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news articles about the company an impact score of 44.8387225017671 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the news articles that may have effected Accern Sentiment’s analysis:

How to Become a New Pot Stock Millionaire

A number of equities analysts recently weighed in on the stock. Mizuho set a $100.00 price target on shares of AmerisourceBergen and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Zacks Investment Research raised shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $103.00 target price on the stock in a research note on Thursday, February 8th. Royal Bank of Canada set a $101.00 price target on shares of AmerisourceBergen and gave the company a “hold” rating in a research note on Monday, April 2nd. Leerink Swann set a $105.00 price target on shares of AmerisourceBergen and gave the company a “buy” rating in a research note on Tuesday, January 2nd. Finally, Credit Suisse Group reissued an “outperform” rating and issued a $112.00 price target (up from $105.00) on shares of AmerisourceBergen in a research note on Wednesday, February 7th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. AmerisourceBergen currently has an average rating of “Buy” and a consensus target price of $102.72.

Shares of AmerisourceBergen stock traded down $1.97 during trading hours on Friday, hitting $85.41. The company had a trading volume of 1,592,695 shares, compared to its average volume of 1,725,752. AmerisourceBergen has a twelve month low of $71.90 and a twelve month high of $106.27. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. The stock has a market cap of $18,761.93, a price-to-earnings ratio of 14.53, a PEG ratio of 1.28 and a beta of 1.06.

AmerisourceBergen (NYSE:ABC) last issued its earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The business had revenue of $40.47 billion during the quarter, compared to analysts’ expectations of $40.42 billion. During the same quarter in the prior year, the business posted $1.36 EPS. The company’s revenue for the quarter was up 6.0% on a year-over-year basis. analysts forecast that AmerisourceBergen will post 6.57 earnings per share for the current fiscal year.

In other AmerisourceBergen news, insider Peyton R. Howell sold 3,000 shares of the company’s stock in a transaction on Wednesday, April 4th. The shares were sold at an average price of $82.72, for a total transaction of $248,160.00. Following the completion of the transaction, the insider now owns 49,189 shares in the company, valued at approximately $4,068,914.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $95.43, for a total transaction of $1,106,988.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 159,809 shares of company stock valued at $14,924,442. 27.30% of the stock is owned by insiders.

TRADEMARK VIOLATION NOTICE: “AmerisourceBergen (NYSE:ABC) Getting Somewhat Positive News Coverage, Accern Reports” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/08/amerisourcebergen-abc-given-media-sentiment-rating-of-0-11.html.

AmerisourceBergen Company Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply